A prandium "comedere" colorectal cancer
In MMXIV: LXV annos et Mr Yang iter uxor ejus foris. Tempore, et gastrointestinal molestiae salubria constipationem facta non fuerit multum vero tempore ratus ut non contenti se multas. Post reversus ad Sinis, per gradus symptoms levatur.
On National Day in 2014, when his son, daughter-in-law, and grandson went home for the holiday, Mr. Yang suddenly had nausea and vomiting when he went to the restaurant to eat. Everyone quickly took him to a nearby large hospital for an examination. Immediately apply for hospitalization.
However, even greater bad news fell from the sky. Further examination showed that Mr. Yang had not appendicitis but colorectal cancer.
In November, Mr Yang resection laparoscopic subire recti semicolon. Plerumque, deploratae colorectal cancer peius multo quam latus a dextra in sinistram partem, sed fortunate, inveni Mr Yang illud et prompte ab ipso smooth est operatio. De morbis ostendit quod gradu II, quod relative diluculo.
Post operationem, Mr Yang rediit ad normalis vitae requiescere post periodum.
Chemotherapy is not effective, the genetic test is negative, is there any help for advanced colorectal cancer?
In May 2016, Mr. Yang clearly felt that he was always tired and fatigued. Sure enough, CT review showed nodules in the anastomosis of the previous operation. Further examination confirmed the recurrence of colorectal cancer and the metastasis of peritoneum and lymph nodes.
He immediately received the FOLFIRI ± cetuximab regimen, but the effect was not satisfactory. Under the advice of the doctor, he conducted a genetic test, and now there are many targeted and immunotherapy medicinae in foro. Quod si non est mutationem, ut esse a argentum oblinit est. Sed eventus erant frustretur. Significantius mutationes test est non inveniri, et microsatellite est firmum, quod significat id quod immune LAPIS inhibitors ea quae nobis acciderint in vita-saving a nascuntur avenae cancer aegris non esse.
Dendritic cellula Vaccinum extrinsecus incidunt omnis removente
Just when the whole family was in despair, a friend in the medical circle recommended Mr. Yang to go to Japan to try dendritic cell vaccine treatment.
This is a dendritic cell vaccine that specifically identifies cancer cells in patients by extracting their own tumor cell antigens, because this is an advanced cell immunotherapy, has no side effects, and even cooperates with normal chemotherapy and targeted therapy Can also increase the effect.
I asked the attending doctor in Sinis, and it was also recognized. The doctor said that although it is impossible to cure, Japan’s cell immunotherapy is indeed at the global leading level. If the economic conditions allow, you can try to achieve the purpose of prolonging survival and improving the quality of life.
MMXVI In August, uxor eius et Mr Yang venit in Japan.
Experimentum eius quaestionis primo, Italica doctores immunes officium quod corporis moles T cellulis preme, idest corporis vires satis occidere cancer cellulis. Moles huius ope voluntatem dendritic Vaccinum chemotherapy et postea curatio, dum e sanguine parare dendritic ad cellulam vaccina.
Statim post primum reinfusion cursum suum, Mr Yang, maxime s obvious ut sensit plena industria animi fuit in corpore. Qui sentiunt ad infirma et infirma, et dolore sunt salubria levaretur. Et appetitus, cibus est non manducare aliquid lucis. cibum.
MMXVI in October, Mr Yang coepit iungere in treatment of cell dendritic vaccine quondam sulum duos weeks.
In MMXVII Ianuarii, in examen eventus mirati sunt omnes DELICTUS, recurrentem et vitia non sunt inventi.
MMXVIII in January, Mr Yang 's re-iterum examen eventus ostendit toto remittuntur; et vitia in corpore sunt omnino remotum est.
Hoc tempore, consilio Mr Yang scriptor curatio statim revertetur omnis sex menses ad id accommodatur, ut ne in idípsum. Ita longe, Yang est Dominus bona valetudo et vita rediit ad normalis.
Quod est curatio dendritic cellula vaccine?
After reading Mr. Yang’s case, I believe that many patients who are not effective for chemotherapy and whose genetic testing does not have targeted drugs see hope.
Dendritic cell vaccine is an ideal therapy. We all know that one of the reasons for the formation of cancer is that cancer cells hide very well. Dendritic cells cannot recognize cancer cells. Imagine that you can put your own cancer cells and dendrites. The cells are fused to form dendritic cells that carry specific antigens on the surface of various cancer cells. These dendritic cells have the ability to recognize tuberculum cells. When we put these cells back into the conductor, he will teach somatic cells to recognize different Cancer antigen cancer cells, one group to find a antigen, one group to find b antigen cancer cells, all of them are eliminated, and at the same time used in combination with the adjuvant therapy of interleukin 12, which enhances T cells in the body, can effectively increase killer T cells The number, so as to achieve the best anti-cancer effect.
Tres commoda dendritic cellula vaccina
1. Ex systemica et loci maxime propria cellularum immune refectionem, id est plus targeted: et accurate pluribus agentibus ad remotionem cancer cellulis.
Eventum variis infectiones morbis communia virales in secretiori parte natium et corporis recta sit ad damna corporis Lunæ munus s DC, sic DC salvum fecit propria corporis fit key munus in in ne et curatio morbo talis. Ob usum certis plurimum epitope peptides, T-DC praebet activated T cellulis specifica et targeted et reparationibus, reficit et adducunt patientes estote proprium cellularum immune munus, solveret corporis immune systemica et loci tolerantia Cum quis status, sic ut consequi refectionem corporis totius loci immunitatem.
2. Perge incipere cum non-cytolysis mechanism remotionem modus ut core occisio cum magno salutem
Studiis ostenditur quod maxime utitur T-DC movens cytokines variis in corpore, sicut patet in pelagus modo ad scopum, ad redigendum qui facit magna damnum ad normalis cellulis, in immune ratio coaptarentur Elisis deinde scopum.
3. Non longum-term effectus habet proprietates Vaccinum est, et in isto passu cognoscit organicum compositum praeventionis et curatio
DC et reparari potest eu in vitro diffunduntur ad requiem T cellulis in corpus ad producendum per initial immune responsum quo rettuli, et activated T cellulis potest ampliari ultra ac multiplicata. Dendrite potest movere unum 100-3000 T cellulis. T cellulis omnium effector ludere a partes in amotio virus, et altera pars superesse pro decades et decades facti memoriam T cellulis. Et iterum expositae sunt, humilis-dose antigens, vir summus intensionem immune responsum non fieri. Unde praesidium in immune ratio fundatur in T-DC opus et munus pro fecundos fructus protulit potet continire ad instaurationem et ad munus exolvuntur potest intrare in re-condiciones oportet.
Quod curatio cancer aegris potest accipere dendritic cellula vaccine?
Est autem considerandum quod dendritic cellula Lorem Vaccinum habet obvious effectus in patientibus proficiebat cancer ab correpta summo tumore effundunt, et per patientiam sustentatur vita patientibus proficiebat cancer habent effectum esse asserens, quod qualis vita est; adjuvant justo ut surgery non relapsus supprimere tractare effici posse diutius; ut cum aliis therapies chemotherapy, targeted medicamentis PD1 inhibitors, et effectus erit magis. Itaque genera quinque aegros aptissimus;
- Isque prius vulneribus aegri corporis infelici tardus recuperare post surgery occulto metu ne revelli amet turpis.
- After radiotherapy and chemotherapy, immunity is low, and side effects are obvio
nos (ut damnum appetitus, nausea, capillos damnum, cutis inflammatio, etc.): de aegris quis expecto effectus, ad augendam ad chemoradiation. - Ex timore de parte effectus ex Rectum et chemotherapy, uti spero, qui aegris treatments ad consequi variis medicinales effectus.
- Leo amet fama per provecta tumores, sed vulgari impotentia curandi ratione et longo sperare salutem meliorem condicionem vitae mollis quis.
- LAPIS inhibitors accepto aegroti esse immunem.
Mainly applicable to solid tumors: head and neck tumors, esophageal cancer, lung cancer, gastric cancer, breast cancer, liver cancer, pancreatic cancer, colorectal cancer, ovarian cancer, cancer uterinus, renal cancer, prostate cancer, malignant melanoma, sarcoma, partial malignancy Lymphoma.
Quam operor aegris domesticis Vaccinum curatio accipere dendritic cellulam?
Hoc tempore, non sunt multi orci in Sina iudicium projects probatus est cellular immunotherapy et valorem, salus et potentia cell DC Lorem adhuc in habitaculo percussoque. Ideo creditum est quod semel consilium altiore est plene launched, et expellam eum in implementation ad operationem pertinet orci treatment options signa, et signa in Sina: et adde novos per treatment of cancer aegris est in Sinis. In Civitatibus Foederatis Americae, Germania, Japan et aliis regionibus cum medicinae signa developed in progressus application et orci in dendritic cells es in forefront of orbis terrarum. Dendritic cellula vaccina Japan in Germania intravit et orci in erat developed prospere application. Et eo probare potes adhibere per Global oncologist Network (XCVI MDLXXXVIII MDLXXXVIII XCI).
Est autem considerandum quod in cellula immunotherapy effectus in patientibus proficiebat cancer est non DECREMENTUM in secretiori parte natium obvious. Pro patientibus proficiebat cancer, quod habet modum per patientiam sustentatur vita servata est qualis est vita; adjuvant curatio est quasi post surgery, eam opprimendam relapsam, et in medicinales effectus non diu Tenere; cum chemotherapy, targeted medicinae therapies PD1 inhibitors et alia est, effectus esse melius.
Cellular immunotherapy is not suitable for all cancer patients. For example, the sARCOMA of Wei Zexi is a rare tumor with a high degree of malignancy. There is currently no good treatment in the world. Therefore, cell immunotherapy is naturally not suitable. Therefore, please ensure that you, family members and patients are kept away from false information on the Internet. Before choosing treatment, it must be evaluated by experts in formal and authoritative cancer hospitals. It is very important to choose carefully according to the economic conditions of the family.
